Micronucleus assay protocols
Bone marrow and peripheral blood micronucleus assays were performed simultaneously in the same animals by double dosing regimen CSGMT, 1990 CSGMT, , 1995 . Maximum doses established in previous studies Hayashi et al., 1989 CSGMT, 1990 , 1992 Morita et al., 1997 Wakata et al., 1998 were used, and set three lower dose levels at a common ratio of two. Untreated animals as the negative control group and no positive control group were used. Each chemical was administered twice orally, 24 h apart, to 5 rats in each of 3 dosage groups, and bone marrow and peripheral blood were collected 24 h 34 
Statistical analysis
To compare the responses of each dosage group with those of the concurrent control group, Kastenbaum and Bowman's tables Kastenbaum and Bowman, 1970 were used for the frequency of MNPCEs, MNRETs, and MNNCEs, and a t-test was used for the frequency of PCEs and RETs. To investigate the effect of sex differences, two-way ANOVA test was used for the frequency of MNPCEs and MNRETs.
Results
The results are shown in Table 2 . In the bone marrow assay, the MNPCE frequency increased significantly in all treated animals. There were significant sex differences in the induction of MNPCE in the Ara-C, CP and MMS treated groups, where the magnitude of the increase was higher in males. The MNNCE frequency increased significantly in the CP, MMS, KBrO 3 , urethane, and Ara-C treated groups but not in the 2-AAF and cholchicine treated groups. The PCE frequency was higher in males in almost all the treatment groups and in the non-treated group.
In the peripheral blood assay, the MNRET frequency increased significantly in the CP, MMS, KBrO 3 , urethane, and Ara-C treated groups. Sex differences were detected significantly in the MMS and urethane treated groups, where the magnitude of the increase was higher in males than in females. The MNNCE frequency increased significantly only in the KBrO 3 treated group. The RET frequency was higher in males in almost all the treatment groups and in the non-treated group.
Discussion
In the bone marrow micronucleus test with MNPCE frequency as the evaluation target, all the chemicals were positive in both sexes but males were significantly more sensitive than females to Ara-C, CP, and MMS. The sex differences might have been caused by differences in chemical bioavailability and metabolism and in erythropoietic function. As for CP, the sex differences may depend on the metabolic activity of cytochrome P450 2C enzyme CYP2C , which metabolizes CP to a genotoxic intermediate Clarke and Waxman, 1989 . The sex differences in PCE frequency seen in this study may reflect sex differences in erythropoietic function. Nagae et al. 1991 suggest that the induction of micronuclei by mutagens is inhibited by treatment with estrogen, and this could result in a sex difference in the sensitivity of mice employed in the micronucleus assay. They also suggest mechanisms of the inhibitory effects of estrogen might include a suppression of erythropoiesis. Yajima et al. 1993a, b, c and Handa and Yajima 1995 speculate that MNPCE frequency increases are the result of errors that occur in the processes of denucleation, differentiation, and repair of genetic damage. They also suggest a close relationship between erythropoiesis and micronucleus induction. The sex differences of body weight may be related to the differences in sensitivity CSGMT, 1986 . When doses were calculated on the body surface, the sex difference tends to lessen data not shown . When MNNCE frequency was the evaluation target, 5 of 7 chemicals were positive, but only weakly, and evaluation of micronucleus induction using NCEs was inappropriate.
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In the peripheral blood micronucleus assay with MNRET frequency as the evaluation target, 2-AAF and cholchicine were negative while the other chemicals were positive in both sexes, with MMS and urethane showing significantly higher responses in the male. Our results reflected that in the rat, the peripheral blood MN assay is less sensitive than the bone marrow MN assay because the rat spleen selectively filters out circulating micronucleated erythrocytes Schlegel and MacGregor, 1984 , especially when the micronuclei are as large as those produced by the spindle poison colchicine. The sex differences in sensitivity may be related to sex differences in erythropoiesis. With MNNCE frequency as the evaluation target, only one chemical KBrO 3 showed positive results, and evaluation of micronucleus induction using NCEs was inappropriate.
In summary, our results showed some sex differences in micronucleus assay sensitivity. These differences may reflect sex differences in erythropoietic function, and the chemical induction of micronuclei in the rat can be evaluated by scoring MNPCEs in the bone marrow or MNRETs in the peripheral blood regardless of sex, with marginal sex differences in sensitivity.
